Iatrogenic Cushing's Syndrome in an HIV-Infected Patient Treated with Inhaled Corticosteroids (Fluticasone Propionate) and Low Dose Ritonavir Enhanced PI Containing Regimen
- 1 April 2002
- journal article
- case report
- Published by Elsevier in Journal of Infection
- Vol. 44 (3) , 194-195
- https://doi.org/10.1053/jinf.2001.0928
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Pharmacokinetic-Pharmacodynamic Consequences and Clinical Relevance of Cytochrome P450 3A4 InhibitionClinical Pharmacokinetics, 2000
- Effects of High-Dose Inhaled Corticosteroids on Plasma Cortisol Concentrations in Healthy AdultsArchives of internal medicine (1960), 1999
- Ritonavir-induced Cushing‚s syndrome in a patient treated with nasal fluticasoneAIDS, 1999
- Fluticasone propionate powder and lack of clinically significant effects on hypothalamic-pituitary-adrenal axis and bone mineral density over 2 years in adults with mild asthmaJournal of Allergy and Clinical Immunology, 1999
- Drug interactions of HIV protease inhibitors.Drug Safety, 1999
- Pharmacokinetic Interaction between Ritonavir and Indinavir in Healthy VolunteersAntimicrobial Agents and Chemotherapy, 1998
- Pharmacokinetic interactions between two human immunodeficiency virus protease inhibitors, ritonavir and saquinavir*Clinical Pharmacology & Therapeutics, 1998
- Pharmacokinetic and pharmacodynamic evaluation of fluticasone propionate after inhaled administrationEuropean Journal of Clinical Pharmacology, 1998
- The human pharmacology of fluticasone propionateRespiratory Medicine, 1990